ACCESSION: MSBNK-SMB_Measured-HSA015P0344005
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'EL03_pos_2707': {'bp': 90326.0, 'sum': 636504.0}, 'EL01_pos_2072': {'bp': 70128.0, 'sum': 464222.0}, 'EL01_pos_2127': {'bp': 56617.0, 'sum': 315987.0}, 'EL03_pos_2589': {'bp': 46436.0, 'sum': 287035.0}, 'EL14_pos_2132': {'bp': 41555.0, 'sum': 247964.0}, 'EL03_pos_2649': {'bp': 40359.0, 'sum': 240664.0}, 'EL01_pos_2189': {'bp': 40284.0, 'sum': 189619.0}, 'EL12_pos_2072': {'bp': 38554.0, 'sum': 255897.0}, 'EL02_pos_2138': {'bp': 33312.0, 'sum': 244989.0}, 'EL14_pos_2195': {'bp': 33161.0, 'sum': 175610.0}, 'EL08_pos_2140': {'bp': 30636.0, 'sum': 168540.0}, 'EL10_pos_2079': {'bp': 29598.0, 'sum': 174956.0}, 'EL01_pos_2249': {'bp': 28895.0, 'sum': 121780.0}, 'EL02_pos_2207': {'bp': 28383.0, 'sum': 139998.0}}
COMMENT: RETENTION_TIME_STDEV 0.332
COMMENT: PRECURSOR_M/Z_RAW 344.133907
COMMENT: PRECURSOR_M/Z_STDEV 0.000167
COMMENT: PRECURSOR_IN_MS1 mz 344.133869; int 65.044; delta(ppm) 1.156469
COMMENT: PROPOSED_CHARGE_STATE +1; mz 345.137800; int 17.748; cor 0.721
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.205; C16H17N5O4; [M+H]+; delta(ppm) -4.205445
COMMENT: PROPOSED_MF SevenGoldenRules 0.309; C15H21NO8; [M+H]+; delta(ppm) -0.308924
COMMENT: PROPOSED_MF SevenGoldenRules 2.705; C9H22N5O7P; [M+H]+; delta(ppm) 2.704541
COMMENT: PROPOSED_MF SevenGoldenRules 3.285; C19H23NOP2; [M+H]+; delta(ppm) 3.284502
COMMENT: PROPOSED_MF MS-FINDER 3.796; C15H21NO8; [M+H]+; delta(ppm) -0.308267
COMMENT: PROPOSED_MF MS-FINDER 2.999; C16H17N5O4; [M+H]+; delta(ppm) -4.194568
COMMENT: PROPOSED_MF MS-FINDER 2.870; C10H18N9O3P; [M+H]+; delta(ppm) -1.191217
COMMENT: PROPOSED_MF MS-FINDER 2.789; C9H22N5O7P; [M+H]+; delta(ppm) 2.695107
COMMENT: PROPOSED_MF MS-FINDER 2.726; C10H26N5O2PS2; [M+H]+; delta(ppm) 0.169869
COMMENT: PROPOSED_MF MS-FINDER 2.666; C16H25NO3S2; [M+H]+; delta(ppm) -2.833490
COMMENT: PROPOSED_MF MS-FINDER 2.628; C8H29N3O5S3; [M+H]+; delta(ppm) -0.940009
COMMENT: PROPOSED_MF MS-FINDER 2.537; C8H21N7O6S; [M+H]+; delta(ppm) -2.301092
COMMENT: PROPOSED_MF MS-FINDER 2.508; C9H30NO6PS2; [M+H]+; delta(ppm) 4.056204
COMMENT: PROPOSED_MF MS-FINDER 2.399; C12H13N11O2; [M+H]+; delta(ppm) 3.608574
COMMENT: PROPOSED_MF MS-FINDER 1.940; C9H25N7OS3; [M+H]+; delta(ppm) -4.826305
COMMENT: PROPOSED_MF MS-FINDER 1.938; C12H21N7OS2; [M+H]+; delta(ppm) 4.969673
COMMENT: PROPOSED_MF MS-FINDER 1.660; C9H33N3S5; [M+H]+; delta(ppm) -3.465229
COMMENT: PROPOSED_MF SIRIUS5_Sirius 71.107; C15H21NO8; [M+H]+; delta(ppm) -0.308267
COMMENT: PROPOSED_MF SIRIUS5_Sirius 68.917; C16H17N5O4; [M+H]+; delta(ppm) -4.194568
COMMENT: PROPOSED_MF SIRIUS5_Sirius 64.241; C19H21NO3S; [M+H]+; delta(ppm) 6.962527
COMMENT: PROPOSED_MF SIRIUS5_Sirius 63.591; C14H22N3O5P; [M+H]+; delta(ppm) -8.994284
COMMENT: PROPOSED_MF SIRIUS5_Sirius 23.047; C14H22ClN5OS; [M+H]+; delta(ppm) -65185.416424
COMMENT: PROPOSED_MF SIRIUS5_Sirius 4.003; C20H14FN5; [M+H]+; delta(ppm) 9.551852
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C15H21NO8; [M+H]+; delta(ppm) -0.308267
COMMENT: PROPOSED_MF SIRIUS6_Sirius 107.224; C15H21NO8; [M+H]+; delta(ppm) -0.308267
COMMENT: PROPOSED_MF SIRIUS6_Sirius 105.034; C16H17N5O4; [M+H]+; delta(ppm) -4.194568
COMMENT: PROPOSED_MF SIRIUS6_Sirius 103.387; C11H17N7O6; [M+H]+; delta(ppm) 7.494936
COMMENT: PROPOSED_MF SIRIUS6_Sirius 100.972; C16H25NO3S2; [M+H]+; delta(ppm) -2.833490
COMMENT: PROPOSED_MF SIRIUS6_Sirius 100.358; C19H21NO3S; [M+H]+; delta(ppm) 6.962527
COMMENT: PROPOSED_MF SIRIUS6_Sirius 96.668; C14H22N3O5P; [M+H]+; delta(ppm) -8.994284
COMMENT: PROPOSED_MF SIRIUS6_Sirius 96.600; C18H19N2O5; [M+H]+; delta(ppm) -8.096094
COMMENT: PROPOSED_MF SIRIUS6_Sirius 95.661; C16H18F3N2O3; [M+H]+; delta(ppm) -0.990564
COMMENT: PROPOSED_MF SIRIUS6_Sirius 95.347; C14H15N8O3; [M+H]+; delta(ppm) -0.293013
COMMENT: PROPOSED_MF SIRIUS6_Sirius 88.215; C15H17B2NO7; [M+H]+; delta(ppm) 61788.423491
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.998; C15H21NO8; [M+H]+; delta(ppm) -0.308267
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C16H17N5O4; [M+H]+; delta(ppm) -4.194568
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.012; QLJKHQIODQKMNW-TVXXKFDONA-N; [M+H]+; OC[C@H]1OC(O)(CN[C@@H](CC2=CC=C(O)C=C2)C(O)=O)[C@@H](O)[C@@H]1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.000; LKEBBKQZHLGWKT-LQRZTCBFSA-N; [M+H]+; C1=CC(=CC=C1CC(C(=O)O)NC2C(C(C(C(O2)CO)O)O)O)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.869; QIZJRPMUYHDGBI-TYPDCKEQNA-N; [M+H]+; N[C@@H](CC1=CC=C(O)C=C1)C(=O)OC[C@@]1(O)O[C@H](CO)[C@@H](O)[C@@H]1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.778; JZAFZYMRELRTKL-QLMHVHEVNA-N; [M+H]+; N[C@@H](CC1=CC=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.771; WWTFANNQTZSANT-IGHBBLSQSA-N; [M+H]+; C1=CC(=CC=C1CC(C(=O)O)NCC(=O)C(C(C(CO)O)O)O)O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.679; JZAFZYMRELRTKL-QLMHVHEVNA-N; [M+H]+; UNPD144912
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.531; QLJKHQIODQKMNW-TVXXKFDONA-N; [M+H]+; N-(1-Deoxy-1-fructosyl)tyrosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.450; QIZJRPMUYHDGBI-TYPDCKEQNA-N; [M+H]+; UNPD121846
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.442; LKEBBKQZHLGWKT-LQRZTCBFSA-N; [M+H]+; (2S)-3-(4-hydroxyphenyl)-2-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.388; WWTFANNQTZSANT-IGHBBLSQSA-N; [M+H]+; (2S)-3-(4-hydroxyphenyl)-2-[[(3S,4R,5R)-3,4,5,6-tetrahydroxy-2-oxohexyl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.353; LZYYZVIACZQHFH-VWNCQVFTSA-N; [M+H]+; UNPD218022
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.427; VOHOFZNVWZWVMA-UHFFFAOYSA-N; [M+H]+; Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.276; ZFSLPLUDYRLKHQ-UHFFFAOYSA-N; [M+H]+; CNP0450510
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.932; VFLMJLOFJMWPKZ-UHFFFAOYSA-N; [M+H]+; 2-{2-[(6-ethoxy-4-methylquinazolin-2-yl)amino]-5-oxo-4,5-dihydro-1H-imidazol-4-yl}acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.822; XQOREDBSVRXZKU-UHFFFAOYSA-N; [M+H]+; 1-{[5-(hydroxymethyl)furan-2-yl]methyl}-5-[3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl]pyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.778; JZOCYZXGWAXKDZ-UHFFFAOYSA-N; [M+H]+; 8-(2,5-dimethoxyphenyl)-1-methyl-1H,2H,3H,4H,6H,7H,8H-imidazo[1,2-g]purine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.740; OZLOLRTXQDIUOG-UHFFFAOYSA-N; [M+H]+; N-(1H-imidazol-2-yl)-2-{1-[(4-methoxyphenyl)methyl]-2,5-dioxoimidazolidin-4-yl}acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.703; SHNIBVWXUOEWTA-UHFFFAOYSA-N; [M+H]+; 4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]benzaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.700; UYSSFUKWIRJRNX-UHFFFAOYSA-N; [M+H]+; 3-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.657; IFIUGVODIUDVSM-UHFFFAOYSA-N; [M+H]+; 2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.524; WGYVNLWYYLACQQ-QJPTWQEYSA-N; [M+H]+; 2-anilino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.468; QVUUUSJUORLECR-VVDYBFHKNA-N; [M+H]+; (2R,3R,4S,5R)-2-(6-anilino-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; OZLOLRTXQDIUOG-UHFFFAOYSA-N; [M+H]+; N-(1H-imidazol-2-yl)-2-{1-[(4-methoxyphenyl)methyl]-2,5-dioxoimidazolidin-4-yl}acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QLJKHQIODQKMNW-TVXXKFDONA-N; [M+H]+; N-(1-Deoxy-1-fructosyl)tyrosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; LKEBBKQZHLGWKT-LQRZTCBFSA-N; [M+H]+; (2S)-3-(4-hydroxyphenyl)-2-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WWTFANNQTZSANT-IGHBBLSQSA-N; [M+H]+; (2S)-3-(4-hydroxyphenyl)-2-[[(3S,4R,5R)-3,4,5,6-tetrahydroxy-2-oxohexyl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.970; JZAFZYMRELRTKL-QLMHVHEVNA-N; [M+H]+; UNPD144912
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.966; VFLMJLOFJMWPKZ-UHFFFAOYSA-N; [M+H]+; 2-{2-[(6-ethoxy-4-methylquinazolin-2-yl)amino]-5-oxo-4,5-dihydro-1H-imidazol-4-yl}acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.931; XQOREDBSVRXZKU-UHFFFAOYSA-N; [M+H]+; 1-{[5-(hydroxymethyl)furan-2-yl]methyl}-5-[3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl]pyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.927; ZFSLPLUDYRLKHQ-UHFFFAOYSA-N; [M+H]+; CNP0450510
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.899; UYSSFUKWIRJRNX-UHFFFAOYSA-N; [M+H]+; 3-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.897; LZYYZVIACZQHFH-VWNCQVFTSA-N; [M+H]+; UNPD218022
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.880; WGYVNLWYYLACQQ-QJPTWQEYSA-N; [M+H]+; 2-anilino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.873; QIZJRPMUYHDGBI-TYPDCKEQNA-N; [M+H]+; UNPD121846
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.871; IFIUGVODIUDVSM-UHFFFAOYSA-N; [M+H]+; 2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.870; SHNIBVWXUOEWTA-UHFFFAOYSA-N; [M+H]+; 4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]benzaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.847; JZOCYZXGWAXKDZ-UHFFFAOYSA-N; [M+H]+; 8-(2,5-dimethoxyphenyl)-1-methyl-1H,2H,3H,4H,6H,7H,8H-imidazo[1,2-g]purine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.841; QVUUUSJUORLECR-VVDYBFHKNA-N; [M+H]+; (2R,3R,4S,5R)-2-(6-anilino-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.394; VOHOFZNVWZWVMA-UHFFFAOYSA-N; [M+H]+; Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.794; MZKPZDRFDHZNND-UHFFFAOYSA-N; [M+H]+; 4-[(2,4-dinitrophenyl)diazenyl]-N,N-diethylaniline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.394; VOHOFZNVWZWVMA-UHFFFAOYSA-N; [M+H]+; ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.040; KZSJOCZJVZXQGN-UHFFFAOYSA-N; [M+H]+; 1-(1,3,7-trimethyl-2,6-dioxopurin-8-yl)ethyl pyridine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; FWMCIFGEKHMBGO-IHWVXMPCSA-N; [M+H]+; (2S)-3-(4-hydroxyphenyl)-2-[[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylamino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.947; DMVJUYDQYGHJIC-MLFYPQLQSA-N; [M+H]+; (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenoxy]oxane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -64.256; JZAFZYMRELRTKL; [M+H]+; Tyrosine glucoside
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -114.957; QLJKHQIODQKMNW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.435; QIZJRPMUYHDGBI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.806; LZYYZVIACZQHFH; [M+H]+; Bauhinin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -382.826; VOHOFZNVWZWVMA; [M+H]+; Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.494; JZAFZYMRELRTKL; [M+H]+; Tyrosine glucoside
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -88.212; JZAFZYMRELRTKL; [M+H]+; 2-amino-3-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.735; LKEBBKQZHLGWKT; [M+H]+; (2S)-3-(4-hydroxyphenyl)-2-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -127.537; QLJKHQIODQKMNW; [M+H]+; 3-(4-hydroxyphenyl)-2-({[2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.123; QIZJRPMUYHDGBI; [M+H]+; [2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl 2-amino-3-(4-hydroxyphenyl)propanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.752; LZYYZVIACZQHFH; [M+H]+; 2-(5-hydroxy-4-methoxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-2-en-1-ylidene)acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -237.125; WWTFANNQTZSANT; [M+H]+; (2R)-3-(4-hydroxyphenyl)-2-[[(3S,4R,5R)-3,4,5,6-tetrahydroxy-2-oxohexyl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -289.178; YWJQJQUXAQAOQH; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -348.825; DMVJUYDQYGHJIC; [M+H]+; Phenylephrine-D-glucuronide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -442.968; VOHOFZNVWZWVMA; [M+H]+; Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.477; JZAFZYMRELRTKL; [M+H]+; 2-amino-3-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)propanoic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C15H22N1O8; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.621
MS$FOCUSED_ION: PRECURSOR_M/Z 344.133887
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-057i-2917000000-40cee6e1aa319421be00
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0336087 107.9115 69.034352 1.4051 18.76 0.9833 12 f{C4H5O1}/1.70ppm,p-C11H17N1O7
  87.0314109 70.9559 87.032113 1.4707 16.08 0.6905 10 f{C3H5N1O2}/-0.79ppm,p-C12H17O6
  91.0542413 84.7093 91.054921 0.8676 18.95 0.8095 10 f{C7H7}/0.16ppm,p-C8H15N1O8
  95.0491481 90.9692 95.049801 0.8943 16.52 0.7364 13 f{C6H7O1}/0.07ppm,p-C9H15N1O7
  97.0283963 125.1877 97.029034 1.2264 21.53 0.9636 13 f{C5H5O2}/-0.10ppm,p-C10H17N1O6
  107.0490723 177.2000 107.049615 1.4012 37.47 0.8818 14 f{C7H7O1}/-0.64ppm,p-C8H15N1O7
  119.0491241 215.1538 119.049572 0.9828 30.28 0.8788 13 f{C8H7O1}/-0.14ppm,p-C7H15N1O7
  121.0647417 77.8845 121.065171 1.2142 18.46 0.6848 11 f{C8H9O1}/-0.41ppm,p-C7H13N1O7
  123.0440581 329.0663 123.044468 1.1459 44.27 0.9909 14 f{C7H7O2}/0.02ppm,p-C8H15N1O6
  136.0756934 291.8738 136.075957 1.2199 54.13 0.9818 14 f{C8H10N1O1}/0.02ppm,p-C7H12O7
  147.0439735 139.7351 147.044266 1.5982 33.07 0.8545 13 f{C9H7O2}/-0.56ppm,p-C6H15N1O6
  148.0756395 330.6527 148.075935 1.2764 65.00 0.9636 14 f{C9H10N1O1}/-0.34ppm,p-C6H12O7
  165.0546672 238.7548 165.055010 1.7509 43.61 0.9333 12 f{C9H9O3}/0.28ppm,p-C6H13N1O5
  182.0811478 232.0492 182.081541 1.5817 32.80 1.0000 11 f{C9H12N1O3}/-0.12ppm,p-C6H10O5
  280.1180073 310.4631 280.118402 1.1424 46.54 0.9879 13 f{C14H18N1O5}/0.21ppm,p-C1H4O3
  308.1128139 479.8058 308.113229 1.1814 76.32 0.8273 14 f{C15H18N1O6}/-0.16ppm,p-H4O2
  326.1233075 999.0000 326.123734 0.5489 0.00 0.9636 14 f{C15H20N1O7}/-0.37ppm,p-H2O1
  327.1264248 164.1853 327.126851 1.1861 27.85 0.8424 13 ?
PK$NUM_PEAK: 18
PK$PEAK: m/z int. rel.int.
  69.033609 107.91 107
  87.031411 70.96 70
  91.054241 84.71 84
  95.049148 90.97 90
  97.028396 125.19 125
  107.049072 177.20 177
  119.049124 215.15 215
  121.064742 77.88 77
  123.044058 329.07 329
  136.075693 291.87 291
  147.043974 139.74 139
  148.075640 330.65 330
  165.054667 238.75 238
  182.081148 232.05 232
  280.118007 310.46 310
  308.112814 479.81 479
  326.123308 999.00 999
  327.126425 164.19 164
//
